"Whisper Numbers"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older Newer

Drmicrocap Free

02/25/17 11:32 AM

Post #121

MSFT beats the "Street" by .04

Drmicrocap Free

02/22/17 10:57 AM

Post #120

IN THE NEWS: HD beats the "Street" by .08

Drmicrocap Free

02/17/17 8:36 AM

Post #119

IN THE NEWS: "Whisper Number" EPS 2.02

Drmicrocap Free

02/16/17 6:22 PM

Post #118

"Whisper Number" AZZ .56

Drmicrocap Free

02/12/17 1:20 AM

Post #117

LGF reports .20

Drmicrocap Free

02/06/17 6:10 PM

Post #116

Breaking News: NWL meets expectations

Drmicrocap Free

02/05/17 5:04 PM

Post #115

IN THE NEWS: SWK beats by .03

Drmicrocap Free

02/02/17 8:38 AM

Post #114

IN THE NEWS: YHOO beats by .04

Drmicrocap Free

02/01/17 1:01 AM

Post #113

IN THE NEWS: JCTCF

Drmicrocap Free

01/31/17 7:40 PM

Post #112

APPL beats "Whisper Number" by .09

Drmicrocap Free

01/30/17 4:38 PM

Post #111

BREAKING NEWS: NTRS

Drmicrocap Free

01/28/17 7:57 AM

Post #110

IN THE NEWS: MSFT

Drmicrocap Free

01/26/17 6:22 AM

Post #109

IN THE NEWS: AZZ "Whisper Number"

Drmicrocap Free

01/26/17 3:38 AM

Post #108

IN THE NEWS: Streets "Whisper Number" XRAY .69

Drmicrocap Free

01/19/17 10:57 AM

Post #107

In The News: "Streets Whisper Number" TTC .40

Drmicrocap Free

01/18/17 4:49 PM

Post #106

Whisper Number $1.27

Drmicrocap Free

01/15/17 8:46 AM

Post #105

IN THE NEWS: NFLX "Whisper Number" .30

Drmicrocap Free

01/13/17 10:35 AM

Post #104

IN THE NEWS: CL "Whisper NUmber" .76

Drmicrocap Free

01/12/17 8:32 PM

Post #103

IN THE NEWS: NKE "Whisper Number" .61

Drmicrocap Free

01/12/17 7:46 AM

Post #102

IN THE NEWS: "Whisper Numbers" $1.44

Drmicrocap Free

12/26/16 10:31 PM

Post #101

In The News: NFLX "Whisper Number" .30

Drmicrocap Free

12/15/16 2:36 AM

Post #100

APPL "Whisper Number" $3.25

Drmicrocap Free

12/13/16 8:16 PM

Post #99

IN THE NEWS; RICK BEATS BY .03

Drmicrocap Free

12/07/16 10:26 PM

Post #98

In The News: COST beats by .06

Drmicrocap Free

12/04/16 1:01 AM

Post #97

In The News: COST

Drmicrocap Free

12/03/16 11:02 AM

Post #96

In The News: MSFT

Drmicrocap Free

11/23/16 10:03 PM

Post #95

In The News: RAI

Drmicrocap Free

11/08/16 2:31 PM

Post #94

XRAY beats by .03

Drmicrocap Free

11/03/16 1:35 AM

Post #93

IN THE NEWS: TSCO

Drmicrocap Free

10/24/16 11:00 AM

Post #92

TTC

Drmicrocap Free

10/21/16 10:43 AM

Post #91

"Whisper Number"

Drmicrocap Free

10/17/16 1:51 PM

Post #90

Whisper Number

Drmicrocap Free

09/16/16 7:22 PM

Post #89

Whisper Numbers

Drmicrocap Free

09/16/16 7:21 PM

Post #88

Drmicrocap

Drmicrocap Free

09/16/16 7:20 PM

Post #87

insert-text-here

Drmicrocap Free

09/06/16 2:54 AM

Post #86

http://drmicrocap.blogspot.com/2016/09/colgate-palmolive-co-cl-eps-estimate-75.html

Drmicrocap Free

08/19/16 6:35 PM

Post #85

Whisper Number

The "Street" has NWL coming in at .77 for the 3rd Quarter ended September 2016 that should be reported on or about October 28, 2016.

All comments welcome.

The "Good Dr's In!"

http://www.whispernumber.com/whisper_profile.jsp?ticker=nwl

Drmicrocap Free

07/29/16 7:54 PM

Post #84

NWL beats Revenue and EPS Estimates

https://finance.yahoo.com/news/newell-rubbermaid-tops-street-2q-104240573.html

Drmicrocap Free

05/24/16 10:19 PM

Post #83

The "Street" has AZZ coming in at .88 for the quarter that should be reported on or about June 29, 2016!

All post's welcome!

The "Good Dr's In"!

Drmicrocap Free

05/03/16 11:57 AM

Post #82

6:37 am Clorox beats by $0.11, beats on revs; raises FY16 guidance (CLX) :

Reports Q3 (Mar) earnings of $1.21 per share, $0.11 better than the Capital IQ Consensus of $1.10; revenues rose 1.8% year/year to $1.43 bln vs the $1.41 bln Capital IQ Consensus.
Co issues raises guidance for FY16, sees EPS of $4.85-4.95 vs. $4.92 Capital IQ Consensus Estimate, up from previous outlook of $4.75 to $4.90. Raises sales growth outlook to 1% to 2% sales growth, or 4% to 5% currency-neutral (previously flat to 1% growth, 3% to 4% currency neutral). Revenue consensus represents +0.8% growth. CLX now sees about 50 basis points of EBIT margin expansion (previously 50-75 basis points).
Third-quarter diluted EPS results were driven largely by gross margin expansion and higher sales, partially offset by higher advertising and sales promotion spending and the impact of unfavorable foreign currency exchange rates.

Drmicrocap Free

05/03/16 10:27 AM

Post #81

The "Street" has XRAY coming in at .65 for the quarter that should be reported on or about May 6, 2016! All post's welcome! The "Good Dr's In"!

Drmicrocap Free

04/29/16 2:28 PM

Post #80

6:36 am Newell Brands beats by $0.02, beats on revs; guides FY16 EPS above consensus (NWL) :

Reports Q1 (Mar) earnings of $0.40 per share, $0.02 better than the Capital IQ Consensus of $0.38; revenues rose 4.0% year/year to $1.31 bln vs the $1.3 bln Capital IQ Consensus. 100 basis point increase in normalized operating margin compared to the prior year, while simultaneously increasing advertising and promotion investment by 40 basis points; 170 basis point increase in reported operating margin compared to the prior year.
Co issues guidance for FY16, sees EPS of $2.75-2.90 vs. $2.60 Capital IQ Consensus Estimate; sees FY16 revs of +3-4% to ~$1.35-1.37 bln, may not be comparable to $13.42 bln Capital IQ Consensus Estimate. As of April 15, 2016, Newell Brands core sales will include pro forma core sales associated with the Jarden transaction as if the combination occurred April 15, 2015. Core sales excludes the impact of foreign currency, all acquisitions until their first anniversary and all planned and completed divestitures (which includes the deconsolidation of Venezuela), but includes the negative impact of planned product line exits.

Drmicrocap Free

04/14/16 4:17 PM

Post #79

The "Street" has TZOO coming in at .11 for the quarter that should be reported on or about April 17, 2016! All post's welcome! The "Good Dr's In"!

Drmicrocap Free

03/31/16 11:52 AM

Post #78

4:39 pm Sonic beats by $0.02, beats on revs; raises FY16 guidance above consensus; finances debt repurchase with new debt offeringBriefing.com (Tue, Mar 29)

Drmicrocap Free

03/18/16 6:20 PM

Post #77

The "Street has AZZ coming in at .70 for the quarter that should be reported on or about April 20, 2016!

All post's welcome!

The "Good Dr's In"!

<eom>

Drmicrocap Free

02/23/16 3:38 PM

Post #76

The "Street has PG coming in at .85 for the quarter that should be reported on or about April 25, 2016! All post's welcome! The "Good Dr's In"!

Drmicrocap Free

02/09/16 1:38 PM

Post #75

The "Street" has LAD coming in at 1.86 for the quarter that should be reported on or about February 24, 2016! All post's welcome! The "Good Dr's In"!

Drmicrocap Free

02/05/16 5:59 PM

Post #74

Colgate Beats 4Q15 Earnings Estimates but Misses on Sales Again
Market Realist By Penny Morgan
4 hours ago
????
Colgate's 4Q15 Results: Earnings Bring Smiles but Sales Dwindle

Colgate’s 4Q15 financial results
Colgate-Palmolive (CL) released its 4Q15 earnings on January 29, 2016. The quarter ended on December 31, 2015. The company’s reported adjusted diluted EPS (or earnings per share) fell 3.9% to $0.73 per share in 4Q15 compared to $0.76 in 4Q14. Revenue was down 7.5% to $3.9 billion.

However, in 4Q15, Colgate-Palmolive came in ahead of consensus Wall Street analyst estimates on earnings after being in line with the estimates for three quarters in a row. Consensus estimates had projected an adjusted diluted EPS of $0.72.

Diluted EPS
On a currency-neutral basis and excluding the after-tax charges on special items including its 2012 restructuring program, its Venezuela accounting change, and other foreign competition charges, the diluted EPS increased by double digits.

Similarly, Procter & Gamble’s (PG) adjusted EPS fell 1.4% while core adjusted earnings per share increased 9% to $1.04 per share in 4Q15. Excluding the impact of currency exchange headwinds, currency-neutral core EPS increased 21% for the quarter. Adjusted EPS for Kimberly-Clark (KMB) also increased to $1.42 in 4Q15 compared to EPS from continuing operations of $1.35 in 4Q15. Clorox (CLX) is yet to announce its 4Q15 results.

Venezuela operations
During 4Q15, the company announced that it will no longer include the results of its Venezuelan operations in its consolidated financial statements. As a result of this change in accounting, Colgate recorded an after-tax charge of $1.1 billion, or $1.18 per diluted share, in 4Q15. This change reflected a significant decrease in the availability of US dollars and other government controls.

As a result, Colgate expects that the change in accounting for its Venezuelan operation will impact diluted EPS in 2016. The company expects diluted EPS to be negative $0.10 for 2016. Colgate makes up 0.7% of the iShares Global 100 ETF (IOO).

In the next article, we will look at Colgate’s revenue estimates and the components that accounted for the decrease in revenues in 4Q15.

Drmicrocap Free

02/05/16 9:50 AM

Post #73

7:02 am WisdomTree reports EPS in-line, beats on revs (WETF) :

Reports Q4 (Dec) earnings of $0.15 per share, in-line with the Capital IQ Consensus of $0.15; revenues rose 54.2% year/year to $76.5 mln vs the $74.59 mln Capital IQ Consensus.
"In challenging market conditions the benefit of the ETF structure becomes even more apparent. Against a backdrop of $125 billion in mutual fund outflows in 2015, the ETF industry enjoyed $232 billion in net inflows."

Drmicrocap Free

01/19/16 11:28 AM

Post #72

The "Street" has NFLX coming in at .04 for the quarter that should be reported on or about January 19, 2016! All post's welcome! The "Good Dr's In"!

Older Newer

"Whisper Numbers"

Followers	0	Posters	2
Posts (Today)	0	Posts (Total)	123
Created	10/21/13	Type	Free
Moderators Drmicrocap

This thread is for those familiar with Quarterly EPS Estimates and the "Streets Whisper Numbers"! The only parameters are as follows: A. Vehicles can meet or exceed a 20% Return on Beginning Common Equity. B. Company's Top Line growth is currently low to mid Single Digit with what appears to be a business model that can meet or Exceed 15% per annum C. EPS growth is currently low to mid Single Digit with what appears to be a business model that can meet or Exceed 15% per annum. There are plenty of them release prior to earnings season so let us know as "The Good Dr's In"! <eom>

Board Info

Posts Today	0
Posts (Total)	123
Posters	2
Moderators	Drmicrocap

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

"Whisper Numbers"

"Whisper Numbers"

Join the InvestorsHub Community

"Whisper Numbers"

Board Info